MULTIMODALITY TREATMENT OF GLIOBLASTOMA PATIENTS USING DIFFERENT TEMOZOLOMIDE REGIMENS IN POSTOPERATIVE CHEMORADIOTHERAPY. Вопр. онкол. [Internet]. 2017 Jun. 1 [cited 2026 Oct. 14];63(6):915-9. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/799